| 1 |
Zheng Y, Zeng L, Dong X, Du Q, Gao Y. Periostin aggravates the early phase of traumatic brain injury via the MAPK/ERK pathway. Neurol Res 2022;:1-10. [PMID: 35001858 DOI: 10.1080/01616412.2021.2024728] [Reference Citation Analysis]
|
| 2 |
Kula A, Dawidowicz M, Mielcarska S, Kiczmer P, Chrabańska M, Rynkiewicz M, Świętochowska E, Waniczek D. Periostin in Angiogenesis and Inflammation in CRC-A Preliminary Observational Study. Medicina (Kaunas) 2022;58:96. [PMID: 35056404 DOI: 10.3390/medicina58010096] [Reference Citation Analysis]
|
| 3 |
Tan S, Khumalo N, Bayat A. Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies. Front Immunol 2019;10:1810. [PMID: 31440236 DOI: 10.3389/fimmu.2019.01810] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 4 |
Liu J, Zhang J, Xu F, Lin Z, Li Z, Liu H. Structural characterizations of human periostin dimerization and cysteinylation. FEBS Lett 2018;592:1789-803. [PMID: 29754429 DOI: 10.1002/1873-3468.13091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 5 |
Labrousse-Arias D, Martínez-Ruiz A, Calzada MJ. Hypoxia and Redox Signaling on Extracellular Matrix Remodeling: From Mechanisms to Pathological Implications. Antioxid Redox Signal 2017;27:802-22. [PMID: 28715969 DOI: 10.1089/ars.2017.7275] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 6 |
Dong XQ, Yu WH, Du Q, Wang H, Zhu Q, Yang DB, Che ZH, Shen YF, Jiang L. Serum periostin concentrations and outcomes after severe traumatic brain injury. Clin Chim Acta 2017;471:298-303. [PMID: 28668564 DOI: 10.1016/j.cca.2017.06.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 7 |
Moniuszko T, Wincewicz A, Koda M, Domysławska I, Sulkowski S. Role of periostin in esophageal, gastric and colon cancer. Oncol Lett 2016;12:783-7. [PMID: 27446351 DOI: 10.3892/ol.2016.4692] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Hu F, Shang XF, Wang W, Jiang W, Fang C, Tan D, Zhou HC. High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma. Int J Exp Pathol 2016;97:86-92. [PMID: 27028305 DOI: 10.1111/iep.12171] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 9 |
Li Z, Zhang X, Yang Y, Yang S, Dong Z, Du L, Wang L, Wang C. Periostin expression and its prognostic value for colorectal cancer. Int J Mol Sci 2015;16:12108-18. [PMID: 26023718 DOI: 10.3390/ijms160612108] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 10 |
Xiao ZM, Wang XY, Wang AM. Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway. Biotechnol Appl Biochem 2015;62:401-6. [PMID: 24372557 DOI: 10.1002/bab.1193] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 11 |
Liu GX, Xi HQ, Sun XY, Wei B. Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis. World J Gastroenterol 2015; 21(9): 2605-2613 [PMID: 25759527 DOI: 10.3748/wjg.v21.i9.2605] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 12 |
Zhang Z, Nie F, Chen X, Qin Z, Kang C, Chen B, Ma J, Pan B, Ma Y. Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin‑1. Mol Med Rep 2015;11:857-64. [PMID: 25369801 DOI: 10.3892/mmr.2014.2827] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Sakellariou GT, Anastasilakis AD, Bisbinas I, Oikonomou D, Gerou S, Polyzos SA, Sayegh FE. Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation. Rheumatology (Oxford) 2015;54:908-14. [PMID: 25349442 DOI: 10.1093/rheumatology/keu425] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
